MicroRNA-122 Promotes Proliferation, Invasion and Migration of Renal Cell Carcinoma Cells Through the PI3K/Akt Signaling Pathway

  • Lian, Ji-Hu (Department of Urology, China-Japan Union Hospital of Jilin University) ;
  • Wang, Wei-Hua (Department of Urology, China-Japan Union Hospital of Jilin University) ;
  • Wang, Jia-Qiang (Department of Urology, Jilin Province People's Hospital) ;
  • Zhang, Yu-Hong (Department of Urology, Jilin Province People's Hospital) ;
  • Li, Yi (Department of Urology, Jilin Province People's Hospital)
  • Published : 2013.09.30


Objective: MicroRNAs (miRNAs) are a small class of non-coding, single-stranded RNAs with a critical role in genesis and maintenance of renal cancer mainly through binding to 3'-untranslated regions (3'UTR) of target mRNAs, which causes a block of translation and/or mRNA degradation. The aim of the present study was to investigate the potential effects of miR-122 in human renal cell carcinomas. Methods: The expression level of miR-122 was quantified by qRT-PCR. MTT, colony formation, invasion and migration assays were used to explore the potential functions of miR-122 in human renal cell carcinoma cells. Results: Cellular growth, invasion and migration in two A498 and 786-O cells were significantly increased after miR-122 transfection. Further experiments demonstrated that overexpression of miR-122 resulted in the increase of phospho-Akt (Ser473) and phospho-mTOR (Ser2448), then activation of mTOR targets, p70S6K and 4E-BP1. Conclusions: The up-regulation of miR-122 may play an important role in the progress of renal cancer through activating PI3K/Akt signal pathway and could be a potential molecular target for anti-cancer therapeutics.


miR-122;renal cell carcinoma;invasion;migration


  1. Esau C, Davis S, Murray SF, et al (2006). miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting. Cell Metab, 3, 87-98.
  2. Bai S, Nasser MW, Wang B, et al (2009). MicroRNA-122 inhibits tumorigenic properties of hepatocellular carcinoma cells and sensitizes these cells to sorafenib. J Biol Chem, 284, 32015-27.
  3. Bartel DP (2004). MicroRNAs: genomics, biogenesis, mechanism, and function. Cell, 116, 281-97.
  4. Bhattacharyya SN, Habermacher R, Martine U, Closs EI, Filipowicz W (2006). Relief of microRNA-mediated translational repression in human cells subjected to stress. Cell, 125, 1111-24.
  5. Chen C, Ridzon DA, Broomer AJ, et al (2005). Real time quantification of microRNAs by stem-loop RT-PCR. Nucleic Acids Res, 33, e179.
  6. Couzin J (2008). MicroRNA make big impression in disease after disease. Science, 319, 1782-4.
  7. Filipowicz W, Bhattacharyya SN, Sonenberg N (2008). Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight? Nat Rev Genet, 9, 102-14.
  8. Heinzelmann J, Henning B, Sanjmyatav J, et al (2011). Specific miRNA signatures are associated with metastasis and poor prognosis in clear cell renal cell carcinoma. World J Urol, 29, 367-73.
  9. Lu J, Getz G, Miska EA, Alvarez-Saavedra E, et al (2005). MicroRNA expression profiles classify human cancers. Nature, 435, 834-8.
  10. Ma L, Liu J, Shen J, et al (2010). Expression of miR-122 mediated by adenoviral vector induces apoptosis and cell cycle arrest of cancer cells. Cancer Biol Ther, 9, 554-61.
  11. Manfe V, Biskup E, Rosbjerg A, et al (2012). miR-122 regulates p53/Akt signaling and the chemotherapy-induced apoptosis in cutaneous T-cell lymphoma. PloS One, 7, e29541
  12. Milowsky MI, Nanus DM (2003). Chemotherapeutic strategies for renal cell carcinoma. Urol Clin North Am, 30, 601-9.
  13. Tsai WC, Hsu SD, Hsu CS, et al (2012). MicroRNA-122 plays a critical role in liver homeostasis and hepatocarcinogenesis. J Clin Invest, 122, 2884-97.
  14. Novick AC (2007). Kidney cancer: past, present, and future. Urol Oncol, 25, 188-95.
  15. Osanto S, Qin Y, Buermans HP, et al (2012). Genome-wide microRNA expression analysis of clear renal cell carcinoma by next generation deep sequencing. PLoS One, 7, e38298.
  16. Rouviere O, Bouvier R, Negrier S, Badet L, Lyonnet D (2006). Nonmetastatic renal-cell carcinoma: is it really possible to define rational guidelines for post-treatment follow-up? Nat Clin Pract Oncol, 3, 200-13.
  17. Wang B, Wang H, Yang Z (2012). MiR-122 inhibits cell proliferation and tumorigenesis of breast cancer by targeting IGF1R. PLoS One, 7, e47053.
  18. Xu J, Zhu X, Wu L, et al (2012). MicroRNA-122 suppresses cell proliferation and induces cell apoptosis in hepatocellular carcinoma by directly targeting Wnt/beta-catenin pathway. Liver Int, 32, 752-60.
  19. Zhou L, Chen J, Li Z, et al (2010). Integrated profiling of microRNAs and mRNAs: microRNAs located on Xq27.3 assoxiate with clear cell renal cell carcinoma. PLoS One, 5, e15224.

Cited by

  1. miR-122/Wnt/β-catenin regulatory circuitry sustains glioma progression vol.35, pp.9, 2014,
  2. Upregulation of microRNA-204 inhibits cell proliferation, migration and invasion in human renal cell carcinoma cells by downregulating SOX4 vol.12, pp.5, 2015,
  3. MicroRNAs in renal cell carcinoma: A systematic review of clinical implications (Review) vol.33, pp.4, 2015,
  4. HBCD and PCBs enhance the cell migration and invasion of HepG2 via the PI3 K/Akt pathway vol.4, pp.3, 2015,
  5. The epigenetic landscape of renal cancer vol.13, pp.1, 2016,
  6. MicroRNA-22 is downregulated in clear cell renal cell carcinoma, and inhibits cell growth, migration and invasion by targeting PTEN vol.13, pp.6, 2016,
  7. miR-122 plays an important role in ochratoxin A-induced hepatocyte apoptosis in vitro and in vivo vol.5, pp.1, 2016,
  8. miR-122 promotes metastasis of clear-cell renal cell carcinoma by downregulating Dicer vol.142, pp.3, 2017,
  9. MiR-122 promotes renal cancer cell proliferation by targeting Sprouty2 vol.39, pp.2, 2017,
  10. High miR-122 expression promotes malignant phenotypes in ccRCC by targeting occludin vol.51, pp.1, 2017,
  11. MicroRNAs in the Pathogenesis of Renal Cell Carcinoma and Their Diagnostic and Prognostic Utility as Cancer Biomarkers vol.31, pp.1, 2016,
  12. Serum miR-122-5p and miR-206 expression: non-invasive prognostic biomarkers for renal cell carcinoma vol.10, pp.1, 2018,
  13. MiRAR—miRNA Activity Reporter for Living Cells vol.9, pp.6, 2018,
  14. Epigenetics in renal cell cancer: mechanisms and clinical applications vol.15, pp.7, 2018,